Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Ayub

Showing results (251-260 of 261) with videos related to

Pageof 27
Sort By:
Psychiatric Genetics|December 20, 2022
Study protocol of DIVERGE, the first genetic epidemiological study of major depressive disorder in PakistanMaria Valkovskaya, Arsalan Hassan, Eirini Zartaloudi, et al.
Nature Neuroscience|March 15, 2016
Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disordersTarjinder Singh, Mitja I Kurki, David Curtis, et al.
Nature Genetics|March 14, 2023
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populationsDongjing Liu, Dara Meyer, Brian Fennessy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 15, 2019
De novo and inherited variants in ZNF292 underlie a neurodevelopmental disorder with features of autism spectrum disorderGhayda M Mirzaa, Jessica X Chong, Amélie Piton, et al.
American Journal of Human Genetics|August 2, 2020
De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function EffectsAndreea Manole, Stephanie Efthymiou, Emer O'Connor, et al.
Pharmacopsychiatry|January 20, 2022
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine LevelsJose de Leon, Georgios Schoretsanitis, Robert L Smith, et al.
Pharmacopsychiatry|December 15, 2021
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine LevelsJose de Leon, Georgios Schoretsanitis, Robert L Smith, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Assigning Targetable Molecular Pathways to Transdiagnostic Subgroups Across Autism and Related Neurodevelopmental DisordersJacob Ellegood, Antoine Beauchamp, Yohan Yee, et al.
Medrxiv : the Preprint Server for Health Sciences|August 12, 2025
A cross-disorder analysis of CNVs finds novel loci and dose-dependent relationships of genes to psychiatric traitsOmar Shanta, Marieke Klein, Molly Sacks, et al.
Medrxiv : the Preprint Server for Health Sciences|August 12, 2025
Psychiatric disorders converge on common pathways but diverge in cellular context, spatial distribution, and directionality of genetic effectsWorrawat Engchuan, Omar Shanta, Kuldeep Kumar, et al.
Pageof 27

Showing results (251-260 of 261) with videos related to

Sort By:
Pageof 27
Psychiatric Genetics|December 20, 2022
Study protocol of DIVERGE, the first genetic epidemiological study of major depressive disorder in PakistanMaria Valkovskaya, Arsalan Hassan, Eirini Zartaloudi, et al.
Nature Neuroscience|March 15, 2016
Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disordersTarjinder Singh, Mitja I Kurki, David Curtis, et al.
Nature Genetics|March 14, 2023
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populationsDongjing Liu, Dara Meyer, Brian Fennessy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 15, 2019
De novo and inherited variants in ZNF292 underlie a neurodevelopmental disorder with features of autism spectrum disorderGhayda M Mirzaa, Jessica X Chong, Amélie Piton, et al.
American Journal of Human Genetics|August 2, 2020
De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function EffectsAndreea Manole, Stephanie Efthymiou, Emer O'Connor, et al.
Pharmacopsychiatry|January 20, 2022
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine LevelsJose de Leon, Georgios Schoretsanitis, Robert L Smith, et al.
Pharmacopsychiatry|December 15, 2021
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine LevelsJose de Leon, Georgios Schoretsanitis, Robert L Smith, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Assigning Targetable Molecular Pathways to Transdiagnostic Subgroups Across Autism and Related Neurodevelopmental DisordersJacob Ellegood, Antoine Beauchamp, Yohan Yee, et al.
Medrxiv : the Preprint Server for Health Sciences|August 12, 2025
A cross-disorder analysis of CNVs finds novel loci and dose-dependent relationships of genes to psychiatric traitsOmar Shanta, Marieke Klein, Molly Sacks, et al.
Medrxiv : the Preprint Server for Health Sciences|August 12, 2025
Psychiatric disorders converge on common pathways but diverge in cellular context, spatial distribution, and directionality of genetic effectsWorrawat Engchuan, Omar Shanta, Kuldeep Kumar, et al.
Pageof 27